statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended...

PureTech Announces Annual Results for Year Ended December 31, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company') plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday...

PureTech Health: Notice of Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...

PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis

PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

I think 2024 could be the year of the mid-cap stock. As we close in on a new UK financial year, there's one FTSE 250 stock in the healthcare sector that I am looking to buy this month.
This index...

Here's one FTSE 250 stock I'd buy in April

PureTech Health plc (NASDAQ:PRTC  Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $29.40, but opened at $28.55. PureTech Health...

PureTech Health (NASDAQ:PRTC) Shares Gap Down to $29.40

PureTech Health plc (NASDAQ:PRTC  Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $27.54, but opened at $29.02. PureTech Health shares last...

PureTech Health (NASDAQ:PRTC) Shares Gap Up to $27.54

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

PureTech Health announces proposed capital return of $100M

PureTech Proposes $100 Million Capital Return

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Volume	294.00
52-Wk High	$34.00
52-Wk Low	$17.08

PRTC Puretech Health

About

Feed

News

Earnings

Fundamentals